Skip to content
Menu

MBX Biosciences, Inc. MBX

Full chart Compare
Set alert

Price alert · MBX

All alert types
49.55 USD -3.86 (-7.23%)

Regular-session close

49.55 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

49.36 Day range 54.43
26.00 52-week range 72.64
YTD
+57.10%
1 year
+83.31%

Held by funds

113 US ETFs and mutual funds hold MBX · largest positions

  1. FBTTX 2.04% of fund $47.93M
  2. VTI 0.00% of fund $47.58M
  3. IWM 0.06% of fund $43.32M
  4. FDSCX 0.56% of fund $41.56M
  5. FSPHX 0.60% of fund $41.03M
  6. FIDGX 0.29% of fund $25.65M
  7. FSSNX 0.06% of fund $20.94M
  8. FHCIX 0.60% of fund $20.22M
  9. NJM 0.03% of fund $20.20M
  10. FFIDX 0.21% of fund $19.78M
  11. VXF 0.02% of fund $18.98M
  12. FBIOX 0.26% of fund $15.72M
  13. IWO 0.12% of fund $15.58M
  14. IBB 0.12% of fund $12.76M
  15. FNITX 0.04% of fund $12.04M
  16. FSCRX 0.53% of fund $11.72M
  17. VTWO 0.06% of fund $10.20M
  18. FBALX 0.01% of fund $10.20M
  19. FBGRX 0.01% of fund $9.97M
  20. XPH 1.80% of fund $9.14M

Ownership

Held by insiders 2.78%
Held by institutions 113.06%
Float held by institutions 116.30%
Institutions 254

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
FMR, LLC14.84%7,368,420365.11MSep 29, 2026
Frazier Life Sciences Management, L.P. 13.40%6,652,013329.61MSep 29, 2026
Wellington Management Group, LLP10.40%5,164,535255.90MSep 29, 2026
Paradigm Biocapital Advisors LP7.60%3,772,885186.95MSep 29, 2026
NEA Management Company, LLC7.28%3,614,486179.10MSep 29, 2026
Blackrock Inc.6.99%3,473,447172.11MSep 29, 2026

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.29%1,135,37556.26MJun 29, 2026
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund1.76%873,49243.28MJun 29, 2026
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund1.65%817,60040.51MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF1.62%805,55739.92MSep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio1.41%700,00034.68MSep 29, 2026
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund1.36%674,70033.43MAug 30, 2026

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs MBX, and what each was last paid

Steven L. Hoerter, Executive Chairperson, CEO & PresidentAverage age 62

MBX key executives
NameTitlePayAge
Steven L. HoerterExecutive Chairperson, CEO & President$40.5K 55
Salomon AzoulayChief Medical Officer$735K 68
John W. SmitherChief Financial Officer$642K 73
Andreas MoraitisSenior Vice President of Clinical Development— —
Karen BasbaumChief Business Officer— —
Michelle GrahamChief Human Resources Officer— 59
Mark HopeChief Regulatory & Quality Officer— —
Mark R. SouedChief Commercial Officer— —
Pete De SpainSenior Vice President of Investor Relations & Corporate Communications— —
Jeffrey HeldChief Legal Officer— 57
Chatan CharanSenior Vice President of Pharmaceutical Development & Chemistry, Manufacturing and Controls— —
Michael A. Dorato DABTSr. Vice President of Discovery & Non-Clinical Development— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

MBX insiders
InsiderRelationLatest transactionDateShares held
AZOULAY SALOMON M.D.OfficerSaleNov 3, 202614,026
BARTRAM RICHARD BChief Financial OfficerStock Award(Grant)Feb 1, 202615,000
GORDON CARL LDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseFeb 17, 20250
HAWRYLUK P KENTChief Executive OfficerSaleMay 5, 20261,214,440
HERON PATRICK JDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseSep 25, 20250
HOERTER STEVEN LChief Executive OfficerSaleNov 9, 202698,045